← Back to headlines
Pfizer's Dividend Future Amid Patent Cliff and Cancer Bet
Analysts are examining whether Pfizer's dividend can withstand an upcoming patent cliff, with a $10.5 billion cancer investment potentially holding the key to its survival.
6 Jun, 17:52 — 6 Jun, 17:52
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Reports Record Second-Quarter Earnings Driven by Surging AI Demand
41m ago
Universal Studios Japan Announces Nearly $2 Billion Expansion Project
1h ago
Nvidia Earnings Fuel Broad Market Rally Ahead of Jackson Hole Symposium
1h ago
Mixed Corporate Earnings Drive Market Movements as Burlington Slides
1h ago